Ectopic pregnancy

Government of Canada releases 2024-2030 Action Plan on Sexually Transmitted and Blood-Borne Infections

Retrieved on: 
Tuesday, February 27, 2024

OTTAWA, ON, Feb. 27, 2024 /CNW/ - Sexually transmitted and blood-borne infections (STBBI) are largely preventable, treatable, and in many cases curable.

Key Points: 
  • OTTAWA, ON, Feb. 27, 2024 /CNW/ - Sexually transmitted and blood-borne infections (STBBI) are largely preventable, treatable, and in many cases curable.
  • However, rates of sexually transmitted infections in Canada have increased over the last decade—gonorrhea rates have doubled since 2012, and syphilis rates are five times what they were.
  • That is why today, the Honourable Mark Holland, Minister of Health, launched the Government of Canada's sexually transmitted and blood-borne infections (STBBI) action plan 2024-2030 and announced $2.45 million in funding to address STBBI in Canada.
  • The Action Plan will continue to work towards reducing STBBI related stigma, to prevent new and reoccurring infections and connect people to testing, prevention, treatment and care."

Pacific Dental Services Marks American Heart Month with Expanded Focus on Oral Health Awareness

Retrieved on: 
Wednesday, February 7, 2024

IRVINE, Calif., Feb. 7, 2024 /PRNewswire/ -- Pacific Dental Services® (PDS), a leading dental and medical support organization in the U.S., is recognizing American Heart Month throughout February with several initiatives that highlight the growing link between oral health and heart health.

Key Points: 
  • IRVINE, Calif., Feb. 7, 2024 /PRNewswire/ -- Pacific Dental Services® (PDS), a leading dental and medical support organization in the U.S., is recognizing American Heart Month throughout February with several initiatives that highlight the growing link between oral health and heart health.
  • "During American Heart Month our focus is on raising awareness about the importance of maintaining optimal oral health — a key contributor to improved heart health," said Stephen E. Thorne, Founder and CEO of Pacific Dental Services.
  • PDS-supported clinicians regularly educate patients about the link between oral health and overall health — also known as the Mouth-Body Connection® .
  • Throughout American Heart Month, PDS is conducting several initiatives to increase awareness about the connection between oral health and heart health, such as:
    Participating in National Wear Red Day to show support and raise awareness for heart health.

Pacific Dental Services Opens First Dental-Medical Integrated Office with MemorialCare

Retrieved on: 
Tuesday, December 5, 2023

IRVINE, Calif. , Dec. 5, 2023 /PRNewswire/ -- Pacific Dental Services® (PDS), one of the leading dental and medical support organizations in the U.S., proudly announces the grand opening of its first co-located dental-medical practice in partnership with MemorialCare, a distinguished Southern California healthcare system. The launch of Culver Smiles Dentistry marks a historic milestone as the first-of-its-kind collaboration between a national dental support organization and a regional healthcare system.

Key Points: 
  • The organizations celebrated the successful launch of an innovative co-located dental and medical practice, revolutionizing integrated healthcare services.
  • IRVINE, Calif. , Dec. 5, 2023 /PRNewswire/ -- Pacific Dental Services® (PDS), one of the leading dental and medical support organizations in the U.S., proudly announces the grand opening of its first co-located dental-medical practice in partnership with MemorialCare , a distinguished Southern California healthcare system.
  • "Today marks an exciting milestone with the opening of Culver Smiles Dentistry, representing a significant leap in healthcare innovation as our inaugural co-located medical and dental practice in partnership with MemorialCare," said Stephen E. Thorne IV, Founder and CEO of Pacific Dental Services.
  • Additionally, offering comprehensive specialty services like endodontics, periodontics, and oral surgery further supports our commitment to providing diverse, patient-centered care within our integrated practice."

Senator Portantino Stops Bill To Hold Oil Drillers Liable For Health Impacts On Community In Undemocratic Use of Unilateral Power To Hold Bills In Committee, Says Consumer Watchdog

Retrieved on: 
Thursday, May 18, 2023

SACRAMENTO, Calif., May 18, 2023 /PRNewswire/ -- SB 556, legislation that gives people who live near oil wells and have developed cancer, respiratory illnesses and birth defects the right to hold oil drillers liable for their illnesses, was held without a vote on the suspense file by the Senate Appropriations Committee. The bill can no longer proceed this year.

Key Points: 
  • Senator Anthony Portantino used his power to stop the bill without a hearing or vote.
  • Oil drillers qualified a referendum that put SB 1137 on hold until voters vote on it in November 2024.
  • Portantino sided with the drillers against the community he represents and allowed oil drillers to continue to recklessly drill without accountability for their actions.
  • We thank Senator Gonzalez for her work to hold the oil industry responsible for the harm they cause.

Bill to Hold Oil Drillers Presumptively Liable For Harms in Drilling Safety Zones Garners Support of 130+ Group Coalition Including Consumer Watchdog, That Powered Through Gasoline Price Gouging Penalty Bill

Retrieved on: 
Tuesday, April 18, 2023

Oil drillers qualified a referendum that put SB 1137 on hold until voters vote on it in November 2024.

Key Points: 
  • Oil drillers qualified a referendum that put SB 1137 on hold until voters vote on it in November 2024.
  • If SB 556 becomes law, it would further protect communities by making drillers liable for the harms they cause starting January 2024.
  • "This bill connects the dots between toxic oil and gas pollution and the health harms it causes.
  • It's high time the onus was put on oil companies to prove their dirty activities aren't the cause of rampant health harms.

FDA Approves Medicines360's LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Eight Years

Retrieved on: 
Monday, November 14, 2022

SAN FRANCISCO, Nov. 14, 2022 /PRNewswire/ -- Medicines360, a global nonprofit organization with a mission to expand women's access to quality medicines, announced today that the U.S. Food and Drug Administration (FDA) has approved Medicines360's Supplemental New Drug Application (sNDA) to extend the duration of use of Liletta® (levonorgestrel-releasing intrauterine system) 52 mg to prevent pregnancy for up to eight years. This approval is based on data from ACCESS IUS (A Comprehensive Contraceptive Efficacy & Safety Study of an IUS) that Medicines360 first published in the American Journal of Obstetrics and Gynecology in May 2022. With this FDA approval, LILETTA has one of the longest approved durations of use for a hormonal intrauterine device (IUD or IUS) in the U.S.

Key Points: 
  • LILETTA was approximately 99% effective in preventing pregnancy for up to eight years in a diverse population of women.
  • LILETTA is a hormone-releasing system placed in the uterus to prevent pregnancy for up to eight years.
  • LILETTA (levonorgestrel-releasing intrauterine system) 52mg is a hormone-releasing system placed in your uterus to prevent pregnancy for as long as you want for up to 8 years.
  • If you get pregnant while using LILETTA, you may have an ectopic pregnancy, which means the pregnancy is not in the uterus.

First Ever “Future of Pregnancy Health” Report Reveals 9 out of 10 New or Expecting Moms Want More Information About Their Individual Risk of Pregnancy Complications to Optimize Prevention

Retrieved on: 
Tuesday, November 8, 2022

Mirvie , a pioneer in predicting unexpected pregnancy complications, today announced the findings of the first ever Future of Pregnancy Health Report .

Key Points: 
  • Mirvie , a pioneer in predicting unexpected pregnancy complications, today announced the findings of the first ever Future of Pregnancy Health Report .
  • The results spotlight an urgent need to identify who is most at risk of complications and tailor education and preventive care toward them.
  • The study also found new or expecting moms overwhelmingly believe knowing their risk of pregnancy complications can enable proactive, personalized and preventive pregnancy care.
  • This new approach to pregnancy health is desperately needed to chart a new course for moms in the United States.

Campaign for Safe Cosmetics Publishes First-Ever List of Top Non-Toxic Black-Owned Beauty Brands & Product Database

Retrieved on: 
Tuesday, October 18, 2022

This project brings health equity to the forefront by providing a database of clean beauty products to help Black women and girls live their healthiest lives and prevent breast cancer.

Key Points: 
  • This project brings health equity to the forefront by providing a database of clean beauty products to help Black women and girls live their healthiest lives and prevent breast cancer.
  • CSC's Top Non-Toxic Black Beauty Brands 2022 > CSC'sNon-Toxic Black Beauty Product Database >
    Released during Breast Cancer Awareness Month, the Non-Toxic Black Beauty Project focuses specifically on supporting Black women's health because Black women face the highest breast cancer mortality rate of any racial or ethnic group in America.
  • Beauty products marketed to Black women often contain the most toxic cosmetics ingredients, including chemicals linked to cancer.
  • "We are thrilled to announce the launch of our searchable database of non-toxic Black beauty products," said Janet Nudelman, Director of the Campaign for Safe Cosmetics, a program of Breast Cancer Prevention Partners.

Mirvie Expands Leadership Team with Appointment of Alison Cowan, M.D. as Head of Medical Affairs

Retrieved on: 
Tuesday, August 30, 2022

Mirvie , a pioneer in predicting unexpected pregnancy complications, today announced the appointment of Alison Cowan, M.D., M.S.C.R.

Key Points: 
  • Mirvie , a pioneer in predicting unexpected pregnancy complications, today announced the appointment of Alison Cowan, M.D., M.S.C.R.
  • View the full release here: https://www.businesswire.com/news/home/20220830005185/en/
    As a practicing OB/GYN, Dr. Cowan brings rigorous clinical experience to our fast-growing team, said Maneesh Jain, Co-Founder and CEO of Mirvie.
  • She received her medical degree and masters in clinical research from Emory University and conducted her OB/GYN residency at Northwestern University.
  • The team at Mirvie is addressing a staggering unmet need, as 1 in 5 pregnancies are impacted by complications,[3]said Dr. Cowan.

On One Year Anniversary, Organon Introduces Global ESG Strategy and Commitments with Publication of Inaugural ESG Report

Retrieved on: 
Thursday, June 2, 2022

Global womens health company, Organon (NYSE: OGN), which employs 9,300 people globally, including 18 in its operations across Israel today announced the publication of its inaugural Environmental, Social, and Governance (ESG) Report for 2021.

Key Points: 
  • Global womens health company, Organon (NYSE: OGN), which employs 9,300 people globally, including 18 in its operations across Israel today announced the publication of its inaugural Environmental, Social, and Governance (ESG) Report for 2021.
  • As a global womens health company, Organon is well positioned to help address several current and growing womens health challenges.
  • As a company investing in innovations to improve womens health, Organon also recognises its responsibility to address this within its own global community.
  • For more details on Organons ESG strategy, priorities, and initiatives, download the full 2021 ESG Report at Organon.com where you can access further information about Organon.